(Q44516845)

English

Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy

scientific article published in June 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

author name string

Tarasi A

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Cassone M

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Monaco M

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Tarasi D

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pompeo ME

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Venditti M

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

239-243

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pathogenesis of foreign body infection. Evidence for a local granulocyte defect

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.239

21 January 2018

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.239

21 January 2018

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.239

21 January 2018

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.239

21 January 2018

Spread of the multiresistant Iberian clone of methicillin-resistant Staphylococcus aureus (MRSA) to Italy and Scotland.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.239

21 January 2018

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.239

21 January 2018

Identifiers

10.1179/JOC.2003.15.3.239

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44516845&oldid=2026598893"